Science Says!
N—143
Welcome to Issue 143 of Science Says! Our weekly newsletter where you’ll learn the latest healthy aging and C15:0 research news that our team of doctors, scientists, and experts are most excited about—without having to go search for it.
Eric and Steph
Co-Founders, Doctors, Nerds
What Dr. Stephanie Venn-Watson, our co-founder and author of The Longevity Nutrient and over 80 peer-reviewed scientific publications, is reading.
Over the past month, we covered two new studies on C15:0 and cardiovascular health in adults. Specifically, Arghavani et al.’s clinical trial showed that increased C15:0 levels significantly correlated with decreased arterial stiffness. Meanwhile, Chen et al. demonstrated that people with circulating C15:0 levels greater than 0.15% of total fatty acids have healthier blood pressure. This week, we talk about a recent study evaluating associations between cell membrane fatty acids and blood pressure in children. Let’s dive in.
Healthy adult hearts start with healthy childhood blood pressure.
As covered by Urbina et al., the higher our blood pressure as children, the greater our risk of developing cardiovascular disease as adults. This is of increasing importance because over the past 40 years, blood pressure has been increasing among kids. And this rise in blood pressure has been independent of the rise in obesity. Thus, protecting healthy blood pressure in children will have a direct, positive effect on protecting our heart health as adults.
Got it. So, where does C15:0 come into the picture?
In their study, Huang et al. measured levels of the following fatty acid groups in the red blood cell membranes of 421 children:
They then assessed whether these fatty acid groups were associated with higher or lower blood pressure in children.
I’m in. What did they find?
Huang et al. had the following key findings related to OSFAs:
In summary, Huang et al.’s study further supports that low C15:0 levels are associated with higher blood pressure – alarmingly, even among children. The good news is that, as demonstrated by multiple clinical trials, our C15:0 levels can be raised by increasing our intake of C15:0. Further, Arghavani et al. showed in their clinical trial that increasing C15:0 levels can improve vascular function within 12 weeks.
A call to action: Restoring C15:0 levels at all ages
Last week, we shared Duan et al.’s study supporting that C15:0 supplementation in infant formulas promotes mitochondrial, gut, and developmental health. This latest study by Huang et al. suggests that children also need adequate C15:0 levels to support healthy blood pressure. Which ladders up to numerous studies showing that we, as aging adults, also need to optimize our C15:0 levels to protect our long-term heart, metabolic, immune, red blood cell, and liver health.
For these reasons, along with robust safety studies, Seraphina Therapeutics has successfully expanded both the dose and age range of pure C15:0 to support our long-term health and wellness, including confirmed Generally Recognized as Safe (GRAS) status for people one year of age and up.
Now, that’s good news for all. Have a wonderful week, everyone!
An Amazon #1 Best Seller
A groundbreaking, once-in-a-century discovery that changes how we can age for the better.
Dr. Mark Hyman
15x New York Times bestseller
By clicking "Accept" you allow cookies that improve your experience on our site, help us analyze site performance and usage, and enable us to show relevant marketing content. See Privacy Policy